Development of PRECISE, a Data-Driven Personalized Suicide Prevention Intervention: Protocol for an Intervention Refinement Pilot and Randomized Controlled Trial

BACKGROUND: Suicidal thoughts and behaviors (STBs) are heterogeneous in their causes and course, yet most interventions rely on nomothetic, one-size-fits-all models. Dialectical behavior therapy (DBT) is an evidence-based treatment for STBs, but its standard year-long format is resource-intensive and difficult to access. Ecological momentary assessment (EMA) combined with idiographic (person-specific) statistical modeling offers a way to identify which emotion regulation processes are driving an individual's risk, and in turn to select the DBT skills most relevant for that person. OBJECTIVE: This protocol describes the refinement (aim 1) and preliminary evaluation (aim 2) of PRECISE (Personalized Clinical Intervention for Suicidal Events), an 8-week, EMA-informed, idiographically tailored adjunctive treatment for adults with active suicidal ideation. METHODS: In aim 1, an existing PRECISE treatment manual and clinician dashboard will be iteratively refined with a mentorship and advisory panel and tested for feasibility and acceptability in a small, randomized pilot study (n=10; n=5 per arm), comparing high- and low-intensity personalization schedules. In aim 2, 60 adults with active suicidal ideation will be randomized to a high-intensity (weekly idiographic model updates across all 8 EMA-monitored weeks) or low-intensity (single idiographic model generated after an initial 2-week EMA burst) version of PRECISE. Both arms will receive coach-delivered DBT skills selected according to each participant's idiographic model, which will be generated using the group iterative multiple model estimation (GIMME) algorithm. Primary outcomes include usability, retention, EMA adherence, acceptability, and fidelity; secondary and exploratory analyses will examine trajectories of suicidal ideation and a within-person mediation model linking emotion regulation to STBs. RESULTS: The trial registration record (ClinicalTrials.gov) was first posted on February 5, 2025, and enrollment began on November 14, 2025. The study is currently recruiting. Estimated total enrollment across aim 1 and aim 2 is 70 participants. Primary and final data collection are anticipated to be complete by March 2030. The study was funded in May 2025, and data collection began in November 2025. As of November 9, 2026, 7 participants had been enrolled. Results are expected to be published in approximately the beginning of 2030. CONCLUSIONS: PRECISE is, to our knowledge, the first idiographically personalized, EMA-informed adjunctive treatment developed specifically for STBs. This trial will provide feasibility, acceptability, and preliminary efficacy data to inform a subsequent fully powered efficacy trial. TRIAL REGISTRATION: ClinicalTrials.gov NCT06809348; https://clinicaltrials.gov/study/NCT06809348. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/109277.

Authors

Institutions

Publication Details

Journal
JMIR Research Protocols
Published
2026-11-18
DOI
https://doi.org/10.2196/109277
Primary Topic
Suicide and Self-Harm Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Development of PRECISE, a Data-Driven Personalized Suicide Prevention Intervention: Protocol for an Intervention Refinement Pilot and Randomized Controlled Trial

Kevin S. Kuehn, Katherine T. Foster, Raeanne Cristine Moore, Colin A. Depp
2 links
JMIR Research Protocols
Suicide and Self-Harm Studies
article

Development of PRECISE, a Data-Driven Personalized Suicide Prevention Intervention: Protocol for an Intervention Refinement Pilot and Randomized Controlled Trial

Kevin S. Kuehn, Katherine T. Foster, Raeanne Cristine Moore, Colin A. Depp
article en

Abstract

BACKGROUND: Suicidal thoughts and behaviors (STBs) are heterogeneous in their causes and course, yet most interventions rely on nomothetic, one-size-fits-all models. Dialectical behavior therapy (DBT) is an evidence-based treatment for STBs, but its standard year-long format is resource-intensive and difficult to access. Ecological momentary assessment (EMA) combined with idiographic (person-specific) statistical modeling offers a way to identify which emotion regulation processes are driving an individual's risk, and in turn to select the DBT skills most relevant for that person. OBJECTIVE: This protocol describes the refinement (aim 1) and preliminary evaluation (aim 2) of PRECISE (Personalized Clinical Intervention for Suicidal Events), an 8-week, EMA-informed, idiographically tailored adjunctive treatment for adults with active suicidal ideation. METHODS: In aim 1, an existing PRECISE treatment manual and clinician dashboard will be iteratively refined with a mentorship and advisory panel and tested for feasibility and acceptability in a small, randomized pilot study (n=10; n=5 per arm), comparing high- and low-intensity personalization schedules. In aim 2, 60 adults with active suicidal ideation will be randomized to a high-intensity (weekly idiographic model updates across all 8 EMA-monitored weeks) or low-intensity (single idiographic model generated after an initial 2-week EMA burst) version of PRECISE. Both arms will receive coach-delivered DBT skills selected according to each participant's idiographic model, which will be generated using the group iterative multiple model estimation (GIMME) algorithm. Primary outcomes include usability, retention, EMA adherence, acceptability, and fidelity; secondary and exploratory analyses will examine trajectories of suicidal ideation and a within-person mediation model linking emotion regulation to STBs. RESULTS: The trial registration record (ClinicalTrials.gov) was first posted on February 5, 2025, and enrollment began on November 14, 2025. The study is currently recruiting. Estimated total enrollment across aim 1 and aim 2 is 70 participants. Primary and final data collection are anticipated to be complete by March 2030. The study was funded in May 2025, and data collection began in November 2025. As of November 9, 2026, 7 participants had been enrolled. Results are expected to be published in approximately the beginning of 2030. CONCLUSIONS: PRECISE is, to our knowledge, the first idiographically personalized, EMA-informed adjunctive treatment developed specifically for STBs. This trial will provide feasibility, acceptability, and preliminary efficacy data to inform a subsequent fully powered efficacy trial. TRIAL REGISTRATION: ClinicalTrials.gov NCT06809348; https://clinicaltrials.gov/study/NCT06809348. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/109277.

JMIR Research ProtocolsVol. 15
University of Washington (US), University of California San Diego (US)
Good health and well-being
Suicide and Self-Harm Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon